Clinicians

LeadCare® II is the only CLIA-waived, point-of-care lead testing system that makes it possible to test, educate and intervene on-the-spot, in one visit. No need to send patients to an outside lab. No need to re-test due to sample problems at the lab. No risk of losing track of a child who needs treatment.

LeadCare® II is the only CLIA-waived, point-of-care lead testing system that makes it possible to test, educate and intervene on-the-spot, in one visit. No need to send patients to an outside lab. No need to re-test due to sample problems at the lab. No risk of losing track of a child who needs treatment.

Immediate results

In 3 minutes, you’ll have the information you need

1 Easy finger stick

It combines with other routine tests

Covered

Most insurance plans cover testing

Saves time

No need for an extra trip to the lab or doctor’s office

Who should be tested?

Have you found the children at risk in your practice?

1 in 38 U.S. children hasharmful blood lead levels. Federal law requires that all Medicaid eligible children be tested at 12 and 24 months and ages 36 to 72 months if they have not previously been tested.

Each state has guidelines or state specific testing requirements for blood lead testing. The American Academy of Pediatrics (AAP) recommends that “children should be tested at least once when they are 2 years of age or, ideally, twice, at 1 and 2 years of age, unless lead exposure can be confidently excluded.”

No safe levels.Evidence continues to grow that blood lead levels as low as 5 ug/dL may impair cognition, with no minimum threshold yet identified.

Early diagnosis helps to quickly address the effects of lead exposure and provides an impetus for lead abatement in homes.

LeadCare II is the onlyCLIA-waived point-of-care blood lead testing system. Any employee of an office or lab operating under a CLIA Certificate of Waiver can administer the test.